GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » 12-1 Month Momentum %

CNTB (Connect Biopharma Holdings) 12-1 Month Momentum % : -19.53% (As of Jul. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-07-23), Connect Biopharma Holdings's 12-1 Month Momentum % is -19.53%.

The industry rank for Connect Biopharma Holdings's 12-1 Month Momentum % or its related term are showing as below:

CNTB's 12-1 Month Momentum % is ranked better than
52.25% of 1422 companies
in the Biotechnology industry
Industry Median: -22.785 vs CNTB: -19.53

Competitive Comparison of Connect Biopharma Holdings's 12-1 Month Momentum %

For the Biotechnology subindustry, Connect Biopharma Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Connect Biopharma Holdings's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's 12-1 Month Momentum % falls into.


;
;

Connect Biopharma Holdings  (NAS:CNTB) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Connect Biopharma Holdings  (NAS:CNTB) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Connect Biopharma Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Connect Biopharma Holdings Business Description

Traded in Other Exchanges
N/A
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CA, USA, 92130
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.